Cowan Chad 4

What Happened
Chad Cowan, Chief Scientific Officer of Century Therapeutics (IPSC), had 1,365 shares withheld by the company to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs). The shares were withheld at $2.19 per share for a total value of $2,989 on April 1, 2026. This is a disposition for tax purposes (transaction code F) and does not represent an open-market sale.

Key Details

• Transaction date: 2026-04-01; Filing date (Form 4): 2026-04-03 — appears timely under the SEC’s two‑business‑day rule.
• Shares withheld: 1,365 shares at $2.19 each; total value $2,989.
• Transaction type: F = shares withheld to satisfy tax withholding on RSU vesting (not a market sale or purchase).
• Shares owned after transaction: Not stated in the provided summary; the filing notes shares may be held in the Cowan Investment Nominee Trust (see footnote).
• Footnotes: F1 — shares withheld to satisfy tax obligations on vesting; F2 — certain shares are held by the Cowan Investment Nominee Trust, and the reporting person disclaims beneficial ownership except for any pecuniary interest.

Context
Tax-withholding dispositions are routine when RSUs vest and generally reflect tax liability rather than a signal of sentiment. This transaction involved no open‑market purchase or sale by the insider and should be viewed as an administrative withholding.